190 related articles for article (PubMed ID: 36868960)
1. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli.
Zeng M; Xia J; Zong Z; Shi Y; Ni Y; Hu F; Chen Y; Zhuo C; Hu B; Lv X; Li J; Liu Z; Zhang J; Yang W; Yang F; Yang Q; Zhou H; Li X; Wang J; Li Y; Ren J; Chen B; Chen D; Wu A; Guan X; Qu J; Wu D; Huang X; Qiu H; Xu Y; Yu Y; Wang M; ; ;
J Microbiol Immunol Infect; 2023 Aug; 56(4):653-671. PubMed ID: 36868960
[TBL] [Abstract][Full Text] [Related]
2. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
[TBL] [Abstract][Full Text] [Related]
3. International guidelines for the treatment of carbapenem-resistant Gram-negative Bacilli infections: A comparison and evaluation.
Wang C; Bai C; Chen K; Du Q; Cheng S; Zeng X; Wang Y; Dong Y
Int J Antimicrob Agents; 2024 May; 63(5):107120. PubMed ID: 38417705
[TBL] [Abstract][Full Text] [Related]
4. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).
Paul M; Carrara E; Retamar P; Tängdén T; Bitterman R; Bonomo RA; de Waele J; Daikos GL; Akova M; Harbarth S; Pulcini C; Garnacho-Montero J; Seme K; Tumbarello M; Lindemann PC; Gandra S; Yu Y; Bassetti M; Mouton JW; Tacconelli E; Rodríguez-Baño J
Clin Microbiol Infect; 2022 Apr; 28(4):521-547. PubMed ID: 34923128
[TBL] [Abstract][Full Text] [Related]
5.
Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?
Apisarnthanarak A; Hsu LY; Khawcharoenporn T; Mundy LM
Expert Rev Anti Infect Ther; 2013 Feb; 11(2):147-57. PubMed ID: 23409821
[TBL] [Abstract][Full Text] [Related]
7. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
[TBL] [Abstract][Full Text] [Related]
8. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria.
Pintado V; Ruiz-Garbajosa P; Aguilera-Alonso D; Baquero-Artigao F; Bou G; Cantón R; Grau S; Gutiérrez-Gutiérrez B; Larrosa N; Machuca I; Martínez Martínez L; Montero MM; Morte-Romea E; Oliver A; Paño-Pardo JR; Sorlí L
Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):360-370. PubMed ID: 36522272
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
Papst L; Beović B; Pulcini C; Durante-Mangoni E; Rodríguez-Baño J; Kaye KS; Daikos GL; Raka L; Paul M;
Clin Microbiol Infect; 2018 Oct; 24(10):1070-1076. PubMed ID: 29410094
[TBL] [Abstract][Full Text] [Related]
10. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
11. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
[TBL] [Abstract][Full Text] [Related]
12. Implementing carbapenem-resistance testing algorithms for Enterobacteriales and Pseudomonas aeruginosa: diagnostic and antimicrobial stewardship with timely infection prevention.
Vega AD; Jimenez A; Rosello G; Claeys KC; Martinez OV; De Pascale B; Perez-Cardona A; Abbo L
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115069. PubMed ID: 32559587
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.
Liang Q; Chen J; Xu Y; Chen Y; Huang M
Antimicrob Resist Infect Control; 2022 Jun; 11(1):89. PubMed ID: 35733230
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
[TBL] [Abstract][Full Text] [Related]
15. All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies.
Lodise TP; Bassetti M; Ferrer R; Naas T; Niki Y; Paterson DL; Zeitlinger M; Echols R
Expert Rev Anti Infect Ther; 2022 May; 20(5):707-719. PubMed ID: 34937518
[TBL] [Abstract][Full Text] [Related]
16. Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China.
Liu K; Xu H; Sun J; Liu Y; Li W
Front Public Health; 2022; 10():1014995. PubMed ID: 36420011
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM).
Tiseo G; Brigante G; Giacobbe DR; Maraolo AE; Gona F; Falcone M; Giannella M; Grossi P; Pea F; Rossolini GM; Sanguinetti M; Sarti M; Scarparo C; Tumbarello M; Venditti M; Viale P; Bassetti M; Luzzaro F; Menichetti F; Stefani S; Tinelli M
Int J Antimicrob Agents; 2022 Aug; 60(2):106611. PubMed ID: 35697179
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.
; Guan X; He L; Hu B; Hu J; Huang X; Lai G; Li Y; Liu Y; Ni Y; Qiu H; Shao Z; Shi Y; Wang M; Wang R; Wu D; Xie C; Xu Y; Yang F; Yu K; Yu Y; Zhang J; Zhuo C
Clin Microbiol Infect; 2016 Mar; 22 Suppl 1():S15-25. PubMed ID: 26627340
[TBL] [Abstract][Full Text] [Related]
19. Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Mouloudi E; Karyoti A; Tsakris A; Roilides E
J Glob Antimicrob Resist; 2020 Mar; 20():214-218. PubMed ID: 31265930
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of carbapenem-resistant Gram-negative infections globally.
Brink AJ
Curr Opin Infect Dis; 2019 Dec; 32(6):609-616. PubMed ID: 31567571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
